Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.31 USD
Change Today -0.85 / -3.40%
Volume 1.9M
CLDX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anthony S. Marucci M.B.A.

Chief Executive Officer, President and Director, Celldex Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
52$3,310,906
As of Fiscal Year 2014

Background*

Mr. Anthony S. Marucci, M.B.A has been the Chief Executive Officer and President of Celldex Therapeutics Inc., (formerly AVANT Immunotherapeutics Inc.) since September 2008. Mr. Marucci served as a Treasurer of BioNJ Inc. Mr. Marucci served as an Interim Chief Executive Officer and Interim President of Celldex Therapeutics Inc., from May 2008 to September 2008 and its Executive Vice President of Corporate Development from July 2008 to October 2008. Mr. Marucci served ...

Read Full Background

Corporate Headquarters*

Perryville III Building
Hampton, New Jersey 08827

United States

Phone: 908-200-7500
Fax: 908-454-1911

Board Members Memberships*

Trustee
2008-Present
Chief Executive Officer, President and Director

Education*

MBA
Columbia University

Other Affiliations*

Annual Compensation*

Salary$520,879
Bonus$293,234
Total Annual Compensation$814,113

Stock Options*

All Other Compensation$64,937
Exercisable Options938,818
Exercisable Options Value$10,483,641
Unexercisable Options606,275
Unexercisable Options Value$3,420,624
Total Value of Options$13,904,264
Total Number of Options1,545,093

Total Compensation*

Total Annual Cash Compensation$879,050
Total Short Term Compensation$814,113
Other Long Term Compensation$64,937
Total Calculated Compensation$3,310,906
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLDX:US $24.31 USD -0.85

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$861.1K
Stanley C. Erck Chief Executive Officer, President, Director and Member of Finance Committee
Novavax, Inc.
$487.8K
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
$886.6K
M. Michelle Berrey M.D., MPH.Chief Executive Officer, President, Chief Medical Officer and Director
Chimerix, Inc.
$419.3K
Paul Chaplin MSc, Ph.D.Chief Executive Officer and President
Bavarian Nordic A/S
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELLDEX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.